Prazosin Hydrochloride
Overview
Prazosin Hydrochloride is an alpha-1 adrenergic receptor antagonist used primarily in the treatment of hypertension, benign prostatic hyperplasia, and post-traumatic stress disorder. It relaxes blood vessels so that blood can flow more easily.
API suppliers (9)
Suppliers of Prazosin Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 9 suppliers.
2 of 9 hold a GMP certificate on record in the EU or UK registers
- SYNTHOKEM LABS PRIVATE LTDIndia1 active DMF
- SUMITOMO CHEMICAL CO LTDJapan GMP on record
- SA AJINOMOTO OMNICHEM NVBelgium
- PROSINTEX INDUSTRIE CHIMIQUE ITALIANE SRL
- PFC ITALIANA SRL DIV ALFA CHEMICALS ITALIANA
- CHEMICAL PHARMACEUTICAL RESEARCH INSTITUTE NIHFI LTD
- STANDARD CHEM AND PHARM CO LTD
- HEUMANN PCS GMBH
- FERMION OYFinland GMP on record
EU CEP holders (1)
Companies holding a valid EU Certificate of Suitability (CEP) for Prazosin Hydrochloride, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.
Therapeutic areas
Do you supply Prazosin Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.